are tirzepatide and semaglutide the same thing vs. for Weight Loss Semaglutide vs. Tirzepatide: Which GLP-1

Two patients can have the exact same injury and follow the exact same rehab protocol but respond very differently if one is significantly under-fueled during recovery

Repurposing of long-acting incretin-based therapies, including the GLP-1 receptor agonist semaglutide, the dual GLP-1/gastric inhibitory polypeptide (GIP) receptor agonist tirzepatide, and the triple GLP-1/GIP/glucagon agonist retatrutide, may offer a promising strategy treating AUD

Even 1015 minutes of daily relaxation practice may benefit metabolic health

The study provided dosing exposure data but did not assess weight-loss efficacy or long-term safety endpoints